Showing 1 - 5 results of 5 for search 'Shi‑wei Jin', query time: 0.04s Refine Results
  1. 1
    Analysis on the difference of volatile flavor compounds of the first round base liquor of sauce-flavor Baijiu with different years

    Analysis on the difference of volatile flavor compounds of the first round base liquor of sauce-flavor Baijiu with different years by SHI Wei, JIN Xinghong, HUANG Ting, WANG Xiangyong, GUO Ju, ZHAO Meimei, YANG Tingting, SHEN Xingtang

    Published 2025-01-01
    Get full text
    Article
  2. 2
    Ixazomib or Lenalidomide combined with cyclophosphamide and dexamethasone in the treatment of elderly transplant-ineligible newly diagnosed multiple myeloma

    Ixazomib or Lenalidomide combined with cyclophosphamide and dexamethasone in the treatment of elderly transplant-ineligible newly diagnosed multiple myeloma by Yan Wang, Yuan-Fang Liu, Shi-Wei Jin, Yi Tao, Wei-Ping Zhang, Jian-Lin Chen, Song-Fu Jiang, Jian-Qing Mi

    Published 2025-02-01
    Get full text
    Article
  3. 3
    PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion

    PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion by Lei Yu, Yan Wang, Jin Wang, Zhiqiang Liu, Feng Liu, Han Zhao, Yi Tao, Jian-Qing Mi, Nan Xu, Wanyan Ouyang, Shi-Wei Jin, Wei-Yang Liu, Liuqingqing Zhang, Liqing Kang, Yuanfang Liu

    Published 2024-04-01
    Get full text
    Article
  4. 4
    P874: LONG-TERM REMISSION AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AFTER TREATMENT OF LCAR-B38M CAR-T – AT LEAST 5-YEAR FOLLOW-UP IN LEGEND-2

    P874: LONG-TERM REMISSION AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AFTER TREATMENT OF LCAR-B38M CAR-T – AT LEAST 5-YEAR FOLLOW-UP IN LEGEND-2 by Jian‑qing MI, Wan‑hong Zhao, Li‑juan Chen, Weijun Fu, Bai‑yan Wang, Jie Xu, Jie Liu, Shi‑wei Jin, Han Zhu, Juan Du, Hua Jiang, Huabin Sun, Yehui Jia, Xiao‑hu Fan, Jian‑yong LI, Jian Hou, Zhu Chen, Wang‑gang Zhang, Ai‑li He, Sai‑juan Chen

    Published 2023-08-01
    Get full text
    Article
  5. 5
    Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

    Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2) by Wan-Hong Zhao, Bai-Yan Wang, Li-Juan Chen, Wei-Jun Fu, Jie Xu, Jie Liu, Shi-Wei Jin, Yin-Xia Chen, Xing-Mei Cao, Yun Yang, Yi-Lin Zhang, Fang-Xia Wang, Peng-Yu Zhang, Bo Lei, Liu-Fang Gu, Jian-Li Wang, Hui Zhang, Ju Bai, Yan Xu, Han Zhu, Juan Du, Hua Jiang, Xiao-Hu Fan, Jian-Yong Li, Jian Hou, Zhu Chen, Wang-Gang Zhang, Jian-Qing Mi, Sai-Juan Chen, Ai-Li He

    Published 2022-07-01
    Get full text
    Article

Search Tools: